Barni Sandro, Venturini Marco, Molino Annamaria, Donadio Michela, Rizzoli Sara, Maiello Evaristo, Gori Stefania
Oncologia Medica, Azienda Ospedaliera Treviglio-Caravaggio, Treviglio, Bergamo, Italy.
Tumori. 2011 Sep-Oct;97(5):559-63. doi: 10.1177/030089161109700503.
Project RIGHT (Research for the Identification of the most effective and hIGHly accepted clinical guidelines for cancer Treatment) is promoted by the Italian Association of Medical Oncology (AIOM) to evaluate the concordance between AIOM breast cancer guidelines and clinical practice in Italy. In RIGHT-1, feasibility and the appropriateness of indicators were assessed in patients with early breast cancer. RIGHT-2 evaluated the compliance with guidelines in a nationwide program.
Thirty-five Italian centers participated in the RIGHT-2 survey. Ten indicators were evaluated to verify an agreement between 2005 AIOM breast cancer guidelines and practice. Patients with clinical stage I-II invasive breast cancer, age ≤70 years, who had their first visit at the oncology center between October 2005 and November 2006 were included.
In RIGHT-2, ≥90% adherence for the diagnosis indicator and three therapy indicators were observed. The lowest degree of compliance (0%) was observed for the follow-up indicator in asymptomatic patients.
In RIGHT-2, compliance to the 2005 AIOM breast cancer guidelines was 64%. When the follow-up indicator was eliminated, overall adherence to AIOM guidelines was 71%. The results highlight the need to continue improving the already good standards of breast cancer care.
RIGHT项目（寻找最有效且广泛接受的癌症治疗临床指南的研究）由意大利医学肿瘤学会（AIOM）发起，旨在评估AIOM乳腺癌指南与意大利临床实践之间的一致性。在RIGHT - 1中，对早期乳腺癌患者指标的可行性和适宜性进行了评估。RIGHT - 2在一项全国性项目中评估了对指南的依从性。
35个意大利中心参与了RIGHT - 2调查。评估了10项指标，以验证2005年AIOM乳腺癌指南与实践之间的一致性。纳入了2005年10月至2006年11月期间在肿瘤中心首次就诊、年龄≤70岁、临床分期为I - II期的浸润性乳腺癌患者。
在RIGHT - 2中，观察到诊断指标和三项治疗指标的依从率≥90%。无症状患者的随访指标依从率最低（0%）。
在RIGHT - 2中，对2005年AIOM乳腺癌指南的依从率为64%。剔除随访指标后，对AIOM指南的总体依从率为71%。结果凸显了继续提高已有良好乳腺癌护理标准的必要性。
